New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 400mg;   - capsule - 400 mg - active: celecoxib 400mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate tekprint green sb-4027 titanium dioxide - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 100 mg/ml;   - solution for injection - 100 mg/ml - active: enoxaparin sodium 100 mg/ml   excipient: water for injection - prophylaxis of venous thromboembolism in general medical patients bedridden due to acute illnesses including acute heart failure, respiratory failure, severe infections, rheumatic disease. prophylaxis of venous thromboembolic disease, in particular those which may be associated with orthopaedic, general, major colorectal or cancer surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 150 mg/ml;   - solution for injection - 150 mg/ml - active: enoxaparin sodium 150 mg/ml   excipient: water for injection - - treatment of venous thromboembolic disease. - prevention of thrombus formation in the extra-corporeal circulation during haemodialysis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - clobetasol propionate 0.5 mg/g;  ;  ;   - shampoo - 0.5 mg/g - active: clobetasol propionate 0.5 mg/g       excipient: citric acid monohydrate coco-betaine ethanol polyquaternium-10 purified water sodium citrate dihydrate sodium laureth sulfate - the topical treatment of moderate to severe scalp psoriasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 100mg;  ;   - tablet - 100 mg - active: amiodarone hydrochloride 100mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone - tachyarrhythmias associated with wolff-parkinson-white syndrome. atrial flutter and fibrillation when other agents cannot be used. all types of tachyarrhythmias of paroxysmal nature including: supraventricular, nodal and ventricular tachycardias, ventricular fibrillation; when other agents cannot be used. tablets are used for stabilisation and long term treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 200mg;  ;   - tablet - 200 mg - active: amiodarone hydrochloride 200mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone - tachyarrhythmias associated with wolff-parkinson-white syndrome. atrial flutter and fibrillation when other agents cannot be used. all types of tachyarrhythmias of paroxysmal nature including: supraventricular, nodal and ventricular tachycardias, ventricular fibrillation; when other agents cannot be used. tablets are used for stabilisation and long term treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 50 mg/ml;   - solution for injection - 150mg/3ml - active: amiodarone hydrochloride 50 mg/ml   excipient: benzyl alcohol polysorbate 80 water for injection - tachyarrhythmias associated with wolff-parkinson-white syndrome. all types of tachyarrhythmias including; supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; ventricular fibrillation; when other agents cannot be used. the injection is to be used when a rapid response is required.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dactinomycin 0.5mg;   - powder for injection - 0.5 mg - active: dactinomycin 0.5mg   excipient: mannitol

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - glibenclamide 5mg;  ; glibenclamide 5mg - tablet - 5 mg - active: glibenclamide 5mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified talc active: glibenclamide 5mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 20 mg/ml - injection (depot) - 20 mg/ml - active: flupentixol decanoate 20 mg/ml excipient: vegetable oil - fluanxol injection is a depot neuroleptic preparation and is indicated in the treatment and maintenance of schizophrenic patients, especially those who are unreliable in taking the medicine prescribed for them.